Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48314 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.46776 | 20 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.46616 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.39271 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.44175 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.55736 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46442 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43597 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.44091 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.46501 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.45009 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.44845 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46434 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.45722 | 19 |